Selleck Chemicals, LLC,as one of the world leading suppliers of biochemical products,dedicates to providing high-quality but inexpensive products of signaling pathways such as MAPK and PI3K/Akt pathways, etc. Its products include potential drug candicates, preclinical medicines in development, small molecule inhibitors in clinical trials, FDA-approved drugs, active pharmaceutical ingredients etc. Currently, Selleck Chemicals have over 1,000 inhibitors as well as a variety of screening libraries. The latter consist of over 2,500 small molecules with validated biological and pharmacological activities. The safety and effectiveness of these molecules has been demonstrated through preclinical and clinical research,and many of them are FDA-approved compounds. In 2013, Selleck Chemicals became a licensed supplier of Pfizer pharmaceuticals, granting its customers access to Pfizer’s exclusive and high quality compounds.Purchased individually or as a library, these compounds have a wide range of applications in preclinical research of human diseases. To continue growing in the biomedical industry, Selleck Chemicals is seeking cooperative licensing with other major pharmaceutical companies. Its products support biomedical investigators to implement their forefront research.As a statistical data in scientific publications,1068 scientific articles referenced Selleck inhibitors in 2013. Among them, 11 were published in top-notch scientific journals (IF>30) Such as Nature, Science and Cell.
|